TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed to providing patients with better alternatives to existing therapies through the research, development and commercialization of small molecule compounds. The company's goal is to develop versatile product candidates each capable of treating a number of acute and chronic diseases and disorders such as migraine, chronic pain, muscle spasticity, xerostomia and cognitive disorders. The company is currently developing three product candidates: two ionotropic glutamate receptor antagonists and one muscarinic receptor agonist.
View Top Employees from TorreyPines Therapeutics , Inc.| Website | http://www.torreypinestherapeutics.com |
| Revenue | $13 million |
| Employees | View employees |
| Address | 11085 N Torrey Pines Rd, Ste 300, La Jolla, California 92037, US |
| Phone | (858) 623-5665 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | GlycoMimetics, Karus Therapeutics Limited, Mimetogen Pharmaceuticals Inc., Rezolute, VTV |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 334 Companies, NAICS Code 33 Companies |
Looking for a particular TorreyPines Therapeutics , Inc. employee's phone or email?
TorreyPines Therapeutics , Inc. Questions
The TorreyPines Therapeutics , Inc. annual revenue was $13 million in 2024.
TorreyPines Therapeutics , Inc. is based in La Jolla, California.
The NAICS codes for TorreyPines Therapeutics , Inc. are [334, 33].
The SIC codes for TorreyPines Therapeutics , Inc. are [283, 28].
